Gain Therapeutics Share Price Today
(NASDAQ: GANX)

Name: Gain Therapeutics Share Price Today (NASDAQ: GANX) - Gain Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Gain Therapeutics share price is $1.8 & ₹153.84 as on 18 Apr 2025, 2.30 'hrs' IST

$1.8

▲

0.06

(3.45%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Gain Therapeutics share price in Dollar and Rupees. Guide to invest in Gain Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gain Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Gain Therapeutics share price movements

Today's Low: $1.72
Today's High: $1.82
$1.80
4.44%
Downside
Day's Volatility :5.49%
Upside
1.1%
52 Weeks Low: $0.89
52 Weeks High: $3.65
$1.80
50.56%
Downside
52 Weeks Volatility :75.62%
Upside
50.68%

Gain Therapeutics (GANX) Returns

Period	Gain Therapeutics Inc	Index (Russel 2000)
3 Months	-17.43%	0.0%
6 Months	-35.48%	0.0%
1 Year	-43.4%	0.0%
3 Years	-51.74%	-12.9%

Gain Therapeutics (GANX) Key Statistics

in dollars & INR

Previous Close	$1.74
Open	$1.75
Today's High	$1.82
Today's Low	$1.72
Market Capitalization	$50.0M
Today's Volume	$149.6K
52 Week High	$3.65
52 Week Low	$0.89
Revenue TTM	$0.0
EBITDA	$-20.3M
Earnings Per Share (EPS)	$-0.89
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-204.95%

How to invest in Gain Therapeutics Stock (GANX) from India?

It is very easy for Indian residents to invest directly in Gain Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gain Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gain Therapeutics or GANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gain Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gain Therapeutics shares which would translate to 0.475 fractional shares of Gain Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gain Therapeutics, in just a few clicks!

Returns in Gain Therapeutics (GANX) for Indian investors in Rupees

The Gain Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Gain Therapeutics investment value today

Current value as on today

₹58,945

Returns

₹41,055

(-41.06%)

Returns from Gain Therapeutics Stock

₹43,396 (-43.4%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Gain Therapeutics (GANX)

-38%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Gain Therapeutics Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gain Therapeutics

Geode Capital Management, LLC
1.01%
Vanguard Group Inc
0.67%
Gotham Asset Management, LLC
0.60%
JONES FINANCIAL COMPANIES LLLP
0.37%
Marshall Wace Asset Management Ltd
0.35%
Morgan Stanley - Brokerage Accounts
0.33%

Analyst Recommendation on Gain Therapeutics

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Gain Therapeutics Stock (GANX)

What analysts predicted

Upside of 344.44%

Target:

$8.00

Current:

$1.80

Insights on Gain Therapeutics Stock (Ticker Symbol: GANX)

Price Movement
In the last 1 month, GANX stock has moved down by -29.6%
GANX vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 121.4%
GANX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 85.1%

Gain Therapeutics Technicals Summary

Sell

Neutral

Buy

Gain Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Gain Therapeutics (GANX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Gain Therapeutics Inc	-24.02%	-35.48%	-43.4%	-51.74%	-83.93%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Gain Therapeutics Inc	NA	NA	NA	-0.66	-2.05	-0.83	NA	0.27
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Gain Therapeutics Inc	Buy	$50.0M	-83.93%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Gain Therapeutics

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of GBA1 Parkinson's disease is being evaluated in a Phase I clinical trials. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is headquartered in Bethesda, Maryland.

Organization	Gain Therapeutics
Employees	23
CEO	Mr. Gene Mack M.B.A.
Industry	Miscellaneous

Management People of Gain Therapeutics

Name	Title
Dr. Khalid Islam Ph.D.	Executive Chairman
Mr. Gene Mack M.B.A.	President, CEO & Director
Mr. Gianluca Fuggetta	Senior VP of Finance & Principal Financial Officer
Dr. Joanne Taylor Ph.D.	Senior Vice President of Research
Dr. Terenzio Ignoni Pharm.D.	Senior Vice President of Technical Operations
Dr. Jonas Hannestad M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in GANX Stock from India :

What is Gain Therapeutics share price today?

Gain Therapeutics share price today stands at $1.80, Open: $1.75 ; Previous Close: $1.74 ; High: $1.82 ; Low: $1.72 ; 52 Week High: $3.65 ; 52 Week Low: $0.89.

The stock opens at $1.75, after a previous close of $1.74. The stock reached a daily high of $1.82 and a low of $1.72, with a 52-week high of $3.65 and a 52-week low of $0.89.

Can Indians buy Gain Therapeutics shares?

Yes, Indians can invest in the Gain Therapeutics (GANX) from India.

With INDmoney, you can buy Gain Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Gain Therapeutics at zero transaction cost.

How can I buy Gain Therapeutics shares from India?

It is very easy to buy Gain Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gain Therapeutics (GANX) be purchased?

Yes, you can buy fractional shares of Gain Therapeutics with INDmoney app.

What are the documents required to start investing in Gain Therapeutics stocks?

To start investing in Gain Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.